Pre-Tax Income: Company's earnings or loss before taxes on income have been accounted for.
Valeant Pharmaceuticals International Inc. (T.BHC) had Pre-Tax Income of 481.84M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
357.23M |
|
-- |
|
-- |
|
-- |
|
1.02B |
|
-- |
|
|
Pre-Tax Income |
481.84M |
481.84M |
|
360.00M |
|
360.00M |
|
360.00M |
|
360.00M |
|
1.02B |
|
1.45B |
|
375.00M |
|
378.10M |
|
0.95 |
|
0.94 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
34.33B |
|
-- |
|
-- |
|
-- |
|
35.44B |
|
-1.11B |
|
-20.46B |
|
-1.11B |
|
373.90M |
|
| Cash Flow Statement Financials | |
1.25B |
|
-321.23M |
|
-206.31M |
|
1.83B |
|
2.54B |
|
710.30M |
|
146.77M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.44 |
|
-- |
|
-- |
|
1.04 |
|
-25.91 |
|
72.93% |
|
25.95% |
|
25.95% |
|
-- |
|
12.20% |
|
9.05% |
|
988.60M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
0.48 |
|
1.26 |
|
71.41 |
|
-32.42% |
|
-1.76% |
|
1.05% |
|
1.36% |
|
-2.97 |
|
2.61 |
|
3.30 |
|